Logo for the Hybrid Event: Clinical Data Disclosure, Transparency, and Plain Language Summaries



In this presentation, Thomas Wicks provides an overview of global clinical trial disclosure regulations, laws, and requirements. He also gives tips on how to ensure consistency of disclosure across registries, and an update on new requirements outside the EU, including Japan.

If you haven’t already done so, you should at least audit … going back to September 2017, your compliance on ClinicalTrials.gov.
Thomas Wicks, Head of Transparency Operations, Citeline

Related resources

Snippet of the word plain in a dictionary.
JUN 14, 2024
Article
薬事規制関連支援サービス

The Growing Need for Plain Language Summaries

A growing number of countries are requiring clinical trials results disclosures in plain language summaries (PLS).

Magnifying glass pie chart data examination transparency
JUL 09, 2024
Article
薬事規制関連支援サービス

The Hidden Implications of Clinical Trial Disclosure Noncompliance

Potential fallout from clinical trial disclosure noncompliance goes beyond regulatory penalties; adherence has improved but less so for smaller companies.

Why Disclosure Matters Now: Presenting the Maturity Model for Clinical Trial Transparency
SEP 04, 2024
Article
薬事規制関連支援サービス

Why Disclosure Matters Now: Presenting the Maturity Model for Clinical Trial Transparency

A comprehensive maturity model for clinical trial disclosure and transparency is a strategic assessment tool for biopharmaceutical companies.